Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups

NCT01645306 is registered in ClinicalTrials.gov with AdvanceCor GmbH as lead sponsor.

NCT NCT01645306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01645306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups
Lead sponsor
AdvanceCor GmbH
Phase
Phase 2
Overall status
Completed
Start date
March 8, 2013
Completion date
September 23, 2019
Enrollment
158 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

amaurosis fugax, atherosclerosis, carotid stenosis, stroke, tia, transient-ischaemic attack